{"id":4394,"date":"2025-01-19T03:28:09","date_gmt":"2025-01-19T03:28:09","guid":{"rendered":"https:\/\/mivado.com\/eshop\/shop\/good-pharmacovigilance-practices-gvp-guidelines\/"},"modified":"2026-10-03T15:01:15","modified_gmt":"2026-10-03T19:01:15","slug":"good-pharmacovigilance-practices-gvp-guidelines","status":"publish","type":"product","link":"https:\/\/mivado.com\/eshop\/eshop\/shop\/good-pharmacovigilance-practices-gvp-guidelines\/","title":{"rendered":"Good Pharmacovigilance Practices (GVP) Guidelines"},"content":{"rendered":"<p>Good pharmacovigilance practices (GVP) are a set of measures designed to facilitate the performance of pharmacovigilance in separate countries.<\/p>\n<p>This comprehensive training program provides an in-depth overview of the Canadian Good Pharmacovigilance Practices (GVP) Guidelines, ensuring compliance with Health Canada regulations. Participants will gain a thorough understanding of the key principles and requirements outlined in the GVP guidelines, covering all aspects of pharmacovigilance activities.<\/p>\n<h2 data-sourcepos=\"7:1-7:24\"><strong>Training Objectives<\/strong><\/h2>\n<ul data-sourcepos=\"9:1-17:0\">\n<li data-sourcepos=\"9:1-9:72\">Understand the scope and applicability of the Canadian GVP Guidelines.<\/li>\n<li data-sourcepos=\"10:1-10:116\">Learn the key principles of pharmacovigilance, including risk management, signal detection, and risk minimization.<\/li>\n<li data-sourcepos=\"11:1-11:92\">Gain knowledge of the regulatory requirements for pharmacovigilance systems and processes.<\/li>\n<li data-sourcepos=\"12:1-12:119\">Develop an understanding of the roles and responsibilities of key personnel involved in pharmacovigilance activities.<\/li>\n<li data-sourcepos=\"13:1-13:98\">Learn to effectively manage adverse event reporting, case processing, and signal management.<\/li>\n<li data-sourcepos=\"14:1-14:90\">Understand the requirements for risk management plans and post-marketing safety studies.<\/li>\n<li data-sourcepos=\"15:1-15:78\">Learn how to comply with regulatory reporting requirements to Health Canada.<\/li>\n<li data-sourcepos=\"16:1-17:0\">Develop practical skills in applying GVP principles to real-world scenarios.<\/li>\n<\/ul>\n<h2 data-sourcepos=\"18:1-18:20\"><strong>Target Audience<\/strong><\/h2>\n<p data-sourcepos=\"20:1-20:94\">This training is designed for individuals involved in pharmacovigilance activities, including:<\/p>\n<ul data-sourcepos=\"22:1-28:0\">\n<li data-sourcepos=\"22:1-22:33\">Pharmacovigilance professionals<\/li>\n<li data-sourcepos=\"23:1-23:25\">Medical safety officers<\/li>\n<li data-sourcepos=\"24:1-24:32\">Regulatory affairs specialists<\/li>\n<li data-sourcepos=\"25:1-25:30\">Clinical research associates<\/li>\n<li data-sourcepos=\"26:1-26:17\">Medical writers<\/li>\n<li data-sourcepos=\"27:1-28:0\">Healthcare professionals involved in drug safety monitoring<\/li>\n<\/ul>\n<h2 data-sourcepos=\"29:1-29:21\"><strong>Training Modules<\/strong><\/h2>\n<ul>\n<li data-sourcepos=\"29:1-29:21\">Module 1: Introduction<\/li>\n<li data-sourcepos=\"29:1-29:21\">Module 2: Serious Adverse Drug Reaction Reporting<\/li>\n<li data-sourcepos=\"29:1-29:21\">Module 3: Periodic Self-inspections &#8211; Personnel and Training<\/li>\n<li data-sourcepos=\"29:1-29:21\">Module 4: Annual Summary Report and Case Reports<\/li>\n<li data-sourcepos=\"29:1-29:21\">Module 5: Issue-related Summary Report &#8211; Maintenance of Records<\/li>\n<li data-sourcepos=\"29:1-29:21\">Module 6: Conclusion<\/li>\n<\/ul>\n<h2>Takeaway<\/h2>\n<p>Additional training documentation and certificates will be provided after the exam. Please note that a minimum score of 80% is required before the training certificate should be issued.<\/p>\n<h2>Author<\/h2>\n<p><a href=\"http:\/\/www.linkedin.com\/in\/kossi-molley-3534923\" target=\"_blank\" rel=\"noopener\">Kossi Molley (il\/he), Chemist, LSSBB; PMP<\/a><br \/>\nChartered Trainer of the Labour Market Partners Commission<\/p>\n<h3>Please<a href=\"https:\/\/mivado.com\/mgp\/contact\/\"> get in touch <\/a>with us for group training!<\/h3>\n","protected":false},"excerpt":{"rendered":"<p>Good pharmacovigilance practices (GVP) are a set of measures designed to facilitate the performance of pharmacovigilance in separate countries. The course explores the activities related to detecting and preventing adverse effects and problems associated with medicines.<\/p>\n","protected":false},"featured_media":4382,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[86],"product_tag":[151,153,125,131,152,122],"class_list":["post-4394","product","type-product","status-publish","has-post-thumbnail","product_cat-e-learning","product_tag-adverse-reaction","product_tag-adverse-reporting","product_tag-gmp","product_tag-health-canada","product_tag-pharmacovigilance","product_tag-quality","first","instock","virtual","sold-individually","taxable","purchasable","product-type-simple"],"wps_subtitle":"English Version","_links":{"self":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/product\/4394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/comments?post=4394"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/media\/4382"}],"wp:attachment":[{"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/media?parent=4394"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/product_brand?post=4394"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/product_cat?post=4394"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/mivado.com\/eshop\/wp-json\/wp\/v2\/product_tag?post=4394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}